Research progress on postoperative adjuvant therapy for esophageal carcinoma / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
;
(6): 945-948, 2019.
Article
in Chinese
| WPRIM
| ID: wpr-800198
ABSTRACT
In China, radical esophagectomy remains the main strategy for resectable esophageal cancer. However, the high locoregional recurrence rate and hematogenous metastasis rate are the main causes of surgical failure. Therefore, whether postoperative adjuvant therapy can become one of the important means for esophageal cancer remains controversial. In this article, the research progress on the postoperative recurrent pattern and adjuvant therapy for esophageal carcinoma was reviewed to provide references for clinicians.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Radiation Oncology
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS